SCHEMBL30982659

SCHEMBL30982659

CCCCCCCCCCCCCCn1ccc(=O)c(OCc2ccccc2)c1C=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ NPC1 O15118 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.46
▸ TLR4 O00206 1/20 0.40
▸ TLR3 O15455 1/20 0.40
▸ TLR5 O60602 1/20 0.40
▸ TLR2 O60603 1/20 0.40
▸ CAMK2B Q13554 1/20 0.40
▸ CAMK2G Q13555 1/20 0.40
▸ CAMK2D Q13557 1/20 0.40
▸ CAMK1 Q14012 1/20 0.40
▸ CAMK4 Q16566 1/20 0.40
▸ PNCK Q6P2M8 1/20 0.40
▸ CAMK1D Q8IU85 1/20 0.40
▸ CAMK1G Q96NX5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30982466 1.00 HTT (0.51) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL30982820 1.00 HTT (0.51) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL3355255 0.90 HTT (0.55) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL30982757 0.90 CNR2 (0.41) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL30982516 0.90 CNR2 (0.41) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL30982975 0.90 CNR2 (0.41) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL30982409 0.88 NPC1 (0.39) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL30982885 0.88 NPC1 (0.39) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL30983036 0.88 NPC1 (0.39) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL2279443 0.85 HTT (0.49) HTTSMN1; SMN2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12606765-B2 Multipurpose oxypyridinones and their functional use—1 INFINEUM INTERNATIONAL LIMITED (US) 2026-04-21 — — US disclosed
US-12606766-B2 Multipurpose oxypyridinones and their functional use-4 INFINEUM INTERNATIONAL LIMITED (US) 2026-04-21 — — US disclosed
US-12503666-B2 Multipurpose oxypyridinones and their functional use-2 INFINEUM INTERNATIONAL LIMITED (US) 2025-12-23 — — US disclosed
US-20240294840-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-2 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 — — US disclosed
US-20240294842-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-4 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 — — US disclosed
US-20240294841-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-3 INFINEUM INTERNATIONAL LIMITED (US) 2024-09-05 — — US disclosed
US-20240287405-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE - 1 INFINEUM INTERNATIONAL LIMITED (US) 2024-08-29 — — US disclosed
EP-4417673-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
EP-4417672-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
EP-4417674-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
EP-4417675-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE Infineum International Limited (GB) 2024-08-21 — — EP disclosed
CN-118516151-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed
CN-118516152-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed
CN-118516153-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed
CN-118516154-A Multipurpose oxypyridones and their functional use 英菲诺姆国际有限公司 2024-08-20 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294840-A1 MULTIPURPOSE OXYPYRIDINONES AND THEIR FUNCTIONAL USE-2 SIGMAR1, OXGR1, OPRM1 HTT 3782/4885SMN1; SMN2 496/4885MEN1 4139/4885
US-12606766-B2 Multipurpose oxypyridinones and their functional use-4 PHOSPHO1, SIGMAR1, SGMS1 HTT 4700/4885SMN1; SMN2 2540/4885MEN1 3637/4885
US-12606765-B2 Multipurpose oxypyridinones and their functional use—1 SIGMAR1, PHOSPHO1, SGMS1 HTT 4463/4885SMN1; SMN2 1840/4885MEN1 3310/4885
US-12503666-B2 Multipurpose oxypyridinones and their functional use-2 SIGMAR1, OXGR1, OPRM1 HTT 3782/4885SMN1; SMN2 496/4885MEN1 4139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback